A Prospective Study of Olanzapine and Aprepitant for CINV in Cisplatin-HAIC for Hepatocellular Carcinoma (PROACT)

Olanzapine and/or aprepitant with granisetron may be effective and safe as an antiemetic therapy in cisplatin-HAIC.

Authors

Institutions

Publication Details

Journal
Anticancer Research
Published
2025-12-30
DOI
https://doi.org/10.21873/anticanres.17953
Primary Topic
Nausea and vomiting management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Prospective Study of Olanzapine and Aprepitant for CINV in Cisplatin-HAIC for Hepatocellular Carcinoma (PROACT)

Hirokazu Mouri, Takahisa Kayahara, Keiko Matsuno, Kinuko Tajima et al.
Anticancer Research
Nausea and vomiting management
article

A Prospective Study of Olanzapine and Aprepitant for CINV in Cisplatin-HAIC for Hepatocellular Carcinoma (PROACT)

Hirokazu Mouri, Takahisa Kayahara, Keiko Matsuno, Kinuko Tajima, Motowo Mizuno, Junya Sakaue, Kenshin Kato, Youichi Morimoto, TOSHIKAZU MORIWAKI, SHUNSUKE OKUYAMA, TAKAHIRO OI, HIROYUKI TAKABATAKE, MASAYUKI UENO, SATORU NISHIKAWA
article en

Abstract

Olanzapine and/or aprepitant with granisetron may be effective and safe as an antiemetic therapy in cisplatin-HAIC.

Anticancer ResearchVol. 46(1)
Kyoto University (JP), Kurashiki Central Hospital (JP)
Zero hunger
Openalex Percentile: Top 25%
Nausea and vomiting management
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.